Pathology

Papers
(The H4-Index of Pathology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation122
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings69
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment52
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent46
Clear cell papillary renal cell carcinoma: an update after 15 years35
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm34
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets34
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays33
Chromophobe renal cell carcinoma: current and controversial issues30
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour27
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection26
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings26
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays25
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-225
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis25
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma23
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship22
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia21
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes21
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour20
Granular necrosis: a distinctive form of cell death in malignant tumours20
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes20
0.050798892974854